Health Care • Biotechnology: Pharmaceutical Preparations
$30.98 ▲ +0.45
(+1.47%)
MKT CAP: $2.23B • VOL: 1.08M
52W L $23 52W H $56
ROARABLE / RQD
E • 31/100
PIOTROSKI
2 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$26
MEDIAN
$35
MEAN
$35
HIGH
$42
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE VERA TAPE
VERA // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $37.49 | $35.63 | 2025-02-14 | $28.19 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $39.03 | $36.56 | 2025-02-06 | $29.12 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $35.32 | $34.08 | 2025-01-29 | $29.74 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $31.60 | — | 2025-01-17 | $30.36 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $27.26 | $29.43 | 2025-01-09 | $27.57 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $36.87 | $32.22 | 2024-12-18 | $26.95 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $30.05 | $31.29 | 2024-12-04 | $28.81 | -4.3% | 48% | C |